| Hang Seng Index | 25.460 HKD | +0.140 | +0.553% | 368.60M | 9.38B | 23.260 (+9.459%) HKD as at 2025/02/25 | | |
| Hang Seng China Enterprises | 92.600 HKD | +0.600 | +0.652% | 83.21M | 7.69B | 86.975 (+6.467%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 5.480 HKD | +0.040 | +0.735% | 1.04B | 5.69B | 5.580 (-1.796%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.635 HKD | +0.080 | +1.440% | 179.77M | 1.01B | 6.590 (-14.492%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.548 HKD | -0.022 | -1.401% | 334.58M | 517.90M | 1.831 (-15.475%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.040 HKD | -0.026 | -1.258% | 127.25M | 259.97M | 2.726 (-25.162%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.695 HKD | +0.065 | +1.155% | 31.13M | 177.15M | 5.000 (+13.907%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 11.750 HKD | +0.090 | +0.772% | 11.72M | 137.61M | 12.133 (-3.154%) HKD as at 2025/02/24 | | |
| Hang Seng China Enterprises | 10.780 HKD | +0.040 | +0.372% | 11.55M | 124.42M | 10.808 (-0.262%) HKD as at 2025/02/24 | | |
| Hang Seng TECH Index | 5.565 HKD | +0.040 | +0.724% | 21.88M | 121.70M | 5.659 (-1.652%) HKD as at 2025/02/25 | | |
| CSI 300 | 46.640 HKD | +0.280 | +0.604% | 1.92M | 89.25M | 43.473 (+7.284%) HKD as at 2025/02/25 | | |
| HSI ESG Enhanced Index (net total return index) | 52.420 HKD | +0.140 | +0.268% | 1.10M | 57.73M | 47.751 (+9.777%) HKD as at 2025/02/25 | | |
| London Gold Fixing Price | 2,433.000 HKD | +13.000 | +0.537% | 18.09K | 43.97M | N/A | | |
| FTSE China A50 | 14.760 HKD | -0.010 | -0.068% | 2.69M | 39.76M | 13.749 (+7.353%) HKD as at 2025/02/24 | | |
| CME Ether Futures | 18.130 HKD | +0.860 | +4.980% | 1.84M | 33.22M | 13.011 (+39.345%) HKD as at 2025/02/24 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 9.130 HKD | +0.440 | +5.063% | 3.04M | 27.52M | 5.740 (+59.068%) HKD as at 2025/02/25 | | |
| Hang Seng High Dividend Yield | 29.500 HKD | +0.380 | +1.305% | 825.68K | 24.25M | 24.714 (+19.365%) HKD as at 2025/02/24 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 15.630 HKD | -0.290 | -1.822% | 1.11M | 17.50M | 10.297 (+51.789%) HKD as at 2025/02/25 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 14.780 HKD | 0.000 | 0.000% | 1.15M | 16.77M | 11.063 (+33.601%) HKD as at 2025/02/25 | | |
| FTSE China A50 | 13.790 HKD | +0.040 | +0.291% | 1.13M | 15.53M | 12.681 (+8.743%) HKD as at 2025/02/25 | | |
| FTSE US Treasury 20+ Years Index | 67.220 HKD | +0.340 | +0.508% | 217.89K | 14.57M | 70.043 (-4.030%) HKD as at 2025/02/24 | | |
| SSE Science and Technology Innovation Board 50 Index | 9.280 HKD | +0.075 | +0.815% | 1.12M | 10.37M | 10.021 (-7.392%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.884 HKD | -0.006 | -0.154% | 2.60M | 10.12M | 4.925 (-21.142%) HKD as at 2025/02/24 | | |
| FTSE 3-Month US Dollar Eurodeposit Index | 118.800 USD | 0.000 | 0.000% | 82.54K | 9.81M | 116.777 (+1.733%) USD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 17.270 HKD | +0.190 | +1.112% | 539.70K | 9.30M | 13.980 (+23.537%) HKD as at 2025/02/24 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.536 HKD | +0.026 | +0.741% | 2.35M | 8.33M | 3.260 (+8.483%) HKD as at 2025/02/25 | | |
| CSI China Reform Hong Kong Connect Central-SOEs High Dividend Yield Index | 9.890 HKD | +0.215 | +2.222% | 832.72K | 8.20M | 8.951 (+10.488%) HKD as at 2025/02/25 | | |
| MSCI China | 25.600 HKD | +0.200 | +0.787% | 315.80K | 8.07M | 23.954 (+6.871%) HKD as at 2025/02/24 | | |
| CSI Hong Kong Dividend | 37.480 HKD | +0.260 | +0.699% | 197.00K | 7.37M | 32.341 (+15.889%) HKD as at 2025/02/25 | | |
| CSI 300 | 42.680 CNY | +0.240 | +0.566% | 171.40K | 7.31M | 40.598 (+5.128%) CNY as at 2025/02/25 | | |